Annual Interest Expense
$7.46 M
-$4.98 M-40.03%
December 31, 2023
Summary
- As of February 7, 2025, AQST annual interest expense is $7.46 million, with the most recent change of -$4.98 million (-40.03%) on December 31, 2023.
- During the last 3 years, AQST annual interest expense has fallen by -$5.56 million (-42.70%).
- AQST annual interest expense is now -66.78% below its all-time high of $22.46 million, reached on December 31, 2021.
Performance
AQST Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$4.20 M
+$3000.00+0.07%
September 30, 2024
Summary
- As of February 7, 2025, AQST quarterly interest expense is $4.20 million, with the most recent change of +$3000.00 (+0.07%) on September 30, 2024.
- Over the past year, AQST quarterly interest expense has increased by +$2.89 million (+219.97%).
- AQST quarterly interest expense is now -36.27% below its all-time high of $6.59 million, reached on September 30, 2021.
Performance
AQST Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$15.83 M
+$2.89 M+22.30%
September 30, 2024
Summary
- As of February 7, 2025, AQST TTM interest expense is $15.83 million, with the most recent change of +$2.89 million (+22.30%) on September 30, 2024.
- Over the past year, AQST TTM interest expense has increased by +$9.90 million (+166.87%).
- AQST TTM interest expense is now -33.17% below its all-time high of $23.68 million, reached on September 30, 2021.
Performance
AQST TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
AQST Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.0% | +220.0% | +166.9% |
| 3 y3 years | -42.7% | +220.0% | +166.9% |
| 5 y5 years | -3.2% | +220.0% | +166.9% |
AQST Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -66.8% | at low | -0.1% | +220.0% | -29.8% | +166.9% |
| 5 y | 5-year | -66.8% | at low | -36.3% | +220.0% | -33.2% | +166.9% |
| alltime | all time | -66.8% | +21.5% | -36.3% | +220.0% | -33.2% | +770.6% |
Aquestive Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.20 M(+0.1%) | $15.83 M(+22.3%) |
| Jun 2024 | - | $4.20 M(-0.1%) | $12.94 M(+27.2%) |
| Mar 2024 | - | $4.20 M(+29.8%) | $10.18 M(+36.4%) |
| Dec 2023 | $7.46 M(-40.0%) | $3.23 M(+146.6%) | $7.46 M(+25.8%) |
| Sep 2023 | - | $1.31 M(-8.1%) | $5.93 M(-28.6%) |
| Jun 2023 | - | $1.43 M(-4.0%) | $8.31 M(-20.5%) |
| Mar 2023 | - | $1.49 M(-12.7%) | $10.45 M(-16.0%) |
| Dec 2022 | $12.44 M(-44.6%) | $1.70 M(-53.8%) | $12.45 M(-13.2%) |
| Sep 2022 | - | $3.69 M(+3.2%) | $14.33 M(-16.8%) |
| Jun 2022 | - | $3.57 M(+2.6%) | $17.23 M(-13.3%) |
| Mar 2022 | - | $3.48 M(-3.0%) | $19.88 M(-11.8%) |
| Dec 2021 | $22.46 M(+72.5%) | $3.59 M(-45.5%) | $22.55 M(-4.8%) |
| Sep 2021 | - | $6.59 M(+5.8%) | $23.68 M(+19.2%) |
| Jun 2021 | - | $6.22 M(+1.2%) | $19.87 M(+21.2%) |
| Mar 2021 | - | $6.15 M(+30.1%) | $16.40 M(+25.9%) |
| Dec 2020 | $13.02 M | $4.73 M(+70.1%) | $13.02 M(+17.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $2.78 M(+1.1%) | $11.10 M(+1.1%) |
| Jun 2020 | - | $2.75 M(-0.9%) | $10.97 M(+8.0%) |
| Mar 2020 | - | $2.77 M(-1.1%) | $10.16 M(+9.1%) |
| Dec 2019 | $9.32 M(+20.8%) | $2.80 M(+5.7%) | $9.32 M(+10.7%) |
| Sep 2019 | - | $2.65 M(+36.9%) | $8.42 M(+9.3%) |
| Jun 2019 | - | $1.94 M(+0.6%) | $7.70 M(+0.1%) |
| Mar 2019 | - | $1.93 M(+1.3%) | $7.69 M(-0.0%) |
| Dec 2018 | $7.71 M(+0.1%) | $1.90 M(-1.6%) | $7.69 M(-0.9%) |
| Sep 2018 | - | $1.93 M(+0.3%) | $7.76 M(-0.5%) |
| Jun 2018 | - | $1.93 M(0.0%) | $7.79 M(-0.3%) |
| Mar 2018 | - | $1.93 M(-2.2%) | $7.82 M(+1.4%) |
| Dec 2017 | $7.71 M(+25.5%) | $1.97 M(0.0%) | $7.71 M(+34.3%) |
| Sep 2017 | - | $1.97 M(+1.1%) | $5.74 M(+52.3%) |
| Jun 2017 | - | $1.95 M(+7.2%) | $3.77 M(+107.2%) |
| Mar 2017 | - | $1.82 M | $1.82 M |
| Dec 2016 | $6.14 M | - | - |
FAQ
- What is Aquestive Therapeutics annual interest expense?
- What is the all time high annual interest expense for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual interest expense year-on-year change?
- What is Aquestive Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly interest expense year-on-year change?
- What is Aquestive Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Aquestive Therapeutics?
- What is Aquestive Therapeutics TTM interest expense year-on-year change?
What is Aquestive Therapeutics annual interest expense?
The current annual interest expense of AQST is $7.46 M
What is the all time high annual interest expense for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual interest expense is $22.46 M
What is Aquestive Therapeutics annual interest expense year-on-year change?
Over the past year, AQST annual interest expense has changed by -$4.98 M (-40.03%)
What is Aquestive Therapeutics quarterly interest expense?
The current quarterly interest expense of AQST is $4.20 M
What is the all time high quarterly interest expense for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly interest expense is $6.59 M
What is Aquestive Therapeutics quarterly interest expense year-on-year change?
Over the past year, AQST quarterly interest expense has changed by +$2.89 M (+219.97%)
What is Aquestive Therapeutics TTM interest expense?
The current TTM interest expense of AQST is $15.83 M
What is the all time high TTM interest expense for Aquestive Therapeutics?
Aquestive Therapeutics all-time high TTM interest expense is $23.68 M
What is Aquestive Therapeutics TTM interest expense year-on-year change?
Over the past year, AQST TTM interest expense has changed by +$9.90 M (+166.87%)